You can buy or sell CTXR and other stocks, options, ETFs, and crypto commission-free!
Citius Pharmaceuticals, Inc. engages in the development and commercialization of therapeutic products. It offers Mino-Lok, a patented solution to treat and salvage infected central venous catheters in patients with catheter related bloodstream infections and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for treatment of hemorrhoids. Read More The company was founded by Ralph Montrone on September 9, 2010 and is headquartered in Cranford, NJ.
Cranford, New Jersey
52 Week High
52 Week Low
Yahoo FinanceMay 1
Citius Pharmaceuticals to Present at the ThinkEquity Conference
CRANFORD, N.J., May 1, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that the Company will present at the ThinkEquity Conference on Thursday, May 2, 2019 at 8:30AM ET. The conference is being held at The Mandarin Oriental Hotel in New York City. During the conference, Executive Chairman, Mr. Leonard Mazur will be giving the presentation as well as answering questions ...
Yahoo FinanceApr 30